Search

Suchformular

Suchen nach:
1281 results:
161. Laske Unit  
1. Longitudinal analysis  of clinical, neuropsychological, biofluid, and imaging modalities in familial Alzheimer's disease for the further understanding of sporadic Alzheimer's disease…  
162. Laske Unit  
Hofmann A, Häsler LM, Lambert M, Kaeser SA, Gräber-Sultan S, Obermüller U, Kuder-Buletta E, la Fougere C, Laske C, Vöglein J, Levin J, Fox NC, Ryan NS, Zetterberg H, Llibre-Guerra JJ, Perrin RJ,…  
163. Jucker Lab  
A seminal finding from our group was the observation that misfolded Aβ can act as a seed to induce further Aß misfolding and aggregation in a manner that is strikingly similar to prion…  
164. Jucker Lab  
Cerebral proteopathy is a unifying term for neurodegenerative diseases in which aggregated proteins are abnormally deposited in the brain. The hallmark proteopathy is Alzheimer’s disease (AD). In…  
165. Jucker Lab  
1. To understand how Aβ aggregation originates, spreads, and leads to neuronal dysfunction and dementia. 2. To study non-Aβ proteopathies in order to determine their similarities and…  
166. Jucker Lab  
Full list of publications   Selected publications Hofmann A, Häsler LM, Lambert M, Kaeser SA, Gräber-Sultan S, Obermüller U, Kuder-Buletta E, la Fougere C, Laske C, Vöglein J, Levin J,…  
167. Jucker Lab  
Cerebral proteopathy is a unifying term for neurodegenerative diseases in which aggregated proteins are abnormally deposited in the brain. The hallmark proteopathy is Alzheimer’s disease (AD). In…  
168. About us  
About us Our research focus is on the cellular and molecular mechanisms of brain aging and age-related neurodegenerative diseases, with a special emphasis on the pathogenesis of Alzheimer's…  
169. About us  
Our research focus is on the cellular and molecular mechanisms of brain aging and age-related neurodegenerative diseases, with a special emphasis on the pathogenesis of Alzheimer's disease and…  
170. Interview with the Deutschlandfunk  
Prof. Matthis Synofzik, head of the section “Translational Genomics of Neurodegenerative Diseases” at the HIH, speaks in an interview with Deutschlandfunk about individually tailored RNA therapies…